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In light of observed changes in connectivity in schizophrenia and the highly heritable
nature of the disease, neural connectivity may serve as an important intermediate phe-
notype for schizophrenia. However, how individual variants confer altered connectivity and
which measure of brain connectivity is more proximal to the underlying genetic architec-
ture (i.e., functional or structural) has not been well delineated. In this review we consider
these issues and the relative sensitivity of imaging methodologies to schizophrenia-related
changes in connectivity. We searched PubMed for studies considering schizophrenia risk
genesAND functional or structural connectivity.Where data was available, summary statis-
tics were used to determine an estimate of effect size (i.e., Cohen’s d ). A random-effects
meta-analysis was used to consider (1) the largest effect and (2) all signiﬁcant effects
between functional and structural studies. Schizophrenia risk variants involved in neuro-
transmission, neurodevelopment and myelin function were found to be associated with
altered neural connectivity. On average, schizophrenia risk genes had a large effect on
functional (mean d= 0.76) and structural connectivity (mean d= 1.04). The examination of
the largest effect size indicated that the outcomes of functional and structural studies were
comparable (Q = 2.17, p> 0.05). Conversely, consideration of effect size estimates for all
signiﬁcant effects suggest that reported effect sizes in structural connectivity studies were
more variable than in functional connectivity studies, and that there was a signiﬁcant lack
of homogeneity across the modalities (Q = 6.928, p = 0.008). Given the more variable pro-
ﬁle of effect sizes associated with structural connectivity, these data may suggest that
structural imaging methods are more sensitive to a wider range of effects, as opposed to
functional studies which may only be able to determine large effects. These conclusions
are limited by methodological considerations, and require further investigation involving
larger samples, multiple genes, and novel analysis techniques for conﬁrmation.
Keywords: schizophrenia, functional connectivity, structural connectivity, genotype, effect size
INTRODUCTION
EXAMINING THE FUNCTION OF SCHIZOPHRENIA (SZ) RISK VARIANTS
Schizophrenia is a complex genetic disorder affecting roughly
1% of the world’s population (see Lewis and Lieberman, 2000
for a review). It is characterized by hallucinations and delu-
sions, reduced emotion and cognitive impairment, and imposes
a heavy cost on society (for example, the total cost of psy-
chotic disorders in Europe in 2010 was recently calculated as
C93.9 billion; Gustavsson et al., 2011). While there is no con-
sensus about its exact causes, the heritability of SZ is esti-
mated to be about 80% (Sullivan et al., 2003). Genome-wide
association (GWAS) and copy number variation studies have
identiﬁed several common and rare gene variants associated
with the disorder (O’Donovan et al., 2008). Understanding the
function of these variants could, therefore, lead to a greater
understanding of disease pathogenesis, which could direct new
treatments.
Schizophrenia patients present with variable symptom proﬁles
and distinct disease trajectories. This heterogeneity may be in part
due to the complex genetics of SZ, which in turn poses signiﬁcant
problems for understanding the mechanisms by which genetic
variants confer risk for this disease. In an attempt to address this
complexity, researchers have focused on so-called “intermediate
phenotypes,” which are measurable variations that occur on the
pathway between genes and disease, and as such may be closer to
the underlying genetic architecture than clinical symptoms (see
Gottesman and Gould, 2003 for a review). Possible intermediate
phenotypes for SZ include changes in brain chemistry, structure,
function (Braff et al., 2007) and connectivity (Meyer-Lindenberg,
2009).
While changes in functional and structural connectivity may
be a critical aspect of the SZ disease proﬁle, there has been little
systematic evaluation of the relative sensitivity of these different
indices to genetic risk for SZ. In this meta-analysis we outline
empirical investigations that have utilized functional magnetic
resonance imaging (fMRI) or diffusion tensor imaging (DTI) to
investigate the effects of SZ risk variants on functional and struc-
tural brain connectivity. We also consider the relative magnitude
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of these effects, in order to determine the extent of the genetic
impact on brain connectivity.
ALTERED FUNCTIONAL CONNECTIVITY IN SZ
In the early 20th century, German neurologist Carl Wernicke pro-
posed that SZ arises from altered neural connectivity (or dyscon-
nectivity) rather than from abnormalities in speciﬁc parts of the
brain (see Stephan et al., 2009 for a review). One hundred years
later, advances in neuroimaging technology have enabled scientists
to empirically consider dysconnectivity as a key component of SZ
pathogenesis.
Two ormore brain regions are said to be functionally connected
if they show a correlation of activity over time (Friston et al.,
1993).The hypothesis that functional connectivity is altered in SZ
is supported by positron emission tomography (PET; e.g., Friston
and Frith, 1995; Meyer-Lindenberg et al., 2001, 2005) and fMRI
studies (Lawrie et al., 2002), which reveal abnormal prefronto-
temporal connectivity in SZ patients while they perform cognitive
tasks. Electroencephalogram (EEG) research also demonstrates
abnormal functional connectivity patterns in patients with SZ
(Breakspear et al., 2003), and one genetic mouse model of SZ
reveals decreased hippocampal-prefrontal connectivity during a
T-maze task (Sigurdsson et al., 2010).
Support for the role of functional connectivity as an interme-
diate phenotype for psychiatric disorders includes a fMRI study
by Pezawas et al., 2005). These authors examined the effects of
a 5-HTTLPRpolymorphism that is associated with anxiety and
depression, on functional connectivity between the amygdala and
cingulate cortex. It was reported that variant-associated changes
in connectivity predicted almost 30% of the variance in the behav-
ioral effects of this polymorphism. Behavioral variability was also
in fact better predicted by changes in connectivity than changes in
regional brain activation.
Understanding the underlying biological causes of altered func-
tional connectivity has the potential to lead to a better understand-
ing of SZpathogenesis,but so far the etiology of functional dyscon-
nectivity remains unclear. However, different mechanisms have
been proposed, which we will discuss in the following sections.
THE “DISCONNECTION” HYPOTHESIS OF SZ
The “disconnection” hypothesis was ﬁrst proposed by Karl Fris-
ton and colleagues in the 1990s (Friston, 1998). This hypothesis
postulates that SZ is primarily caused by abnormal N -methyl-d-
aspartate (NMDA)-receptormediated synaptic plasticity,which in
turn, is caused by dysregulation of these receptors by neurotrans-
mitters such as dopamine. Support for the role of the NMDA
receptor in SZ comes from several studies. Firstly, drugs that
block the NMDA-receptor, such as ketamine and phencyclidine,
can induce psychotic symptoms in healthy controls (see Javitt,
2010 for a review). Similarly, ketamine administration induces
sensory processing deﬁcits in controls similar to deﬁcits seen in
patients, suggesting a role for NMDA receptors in these deﬁcits
(Umbricht et al., 2000). Activity of midbrain dopaminergic neu-
rons is partially regulated by glutamatergic projections from the
prefrontal cortex (PFC), acting via NMDA receptors, and NMDA
receptor-blockade enhances amphetamine-induced increases in
striatal dopamine in controls, similar to increases seen in SZ
patients (Kegeles et al., 2000). Finally, genetic variants that play
a role in NMDA-signaling have been associated with increased
SZ risk in candidate gene studies [e.g., G72,GRM3 and RGS4; see
Harrison andWeinberger (2005) for a review].
FUNCTIONAL CONNECTIVITY MRI ANALYSIS TECHNIQUES
Functional connectivity can be measured with a variety of tools
(e.g., PET,EEG), but this reviewwill focus on papers using fMRI to
measure the phenotype in healthy controls and patients with SZ.
Using the blood oxygen level dependent (BOLD) response as an
indirect measure of neuronal activity (Ogawa et al., 1990), there
are a range of approaches to analysis. This review will focus on
seeded connectivity and psychophysiological interaction (PPI).
A seeded connectivity analysis begins with the selection of a
seed region, which can be a voxel, or cluster of voxels in the fMRI
time-series (Nallasamy and Tsao, 2011). The mean time-course
for the seed region is then correlated with all other voxels in the
brain. Voxels that pass a certain threshold are considered to be
functionally connected with the seed region, resulting in a func-
tional connectivitymap.While the PPI approach alsomeasures the
co-variation of the BOLD signal in voxels across the brain (Friston
et al., 1997), it also measures changes in the interactions between
brain regions in response to different psychological tasks.
STRUCTURAL CONNECTIVITY AND SZ
White matter (WM) contains myelinated nerve cells that con-
nect various gray matter (GM) areas of the brain to each other,
and carry nerve impulses between neurons. Compromised WM
integrity is evident in SZ (Kubicki et al., 2007; Ellison-Wright and
Bullmore, 2009). Moreover, WM abnormalities are apparent in
individuals at high risk of SZ and also in patients during the early
stages of illness, suggesting that these abnormalitiesmay be a stable
characteristic of the disease (Witthaus et al., 2008; Perez-Iglesias
et al., 2010). There are two key postulations regarding the nature
of WM deﬁcits in SZ: The “global theory” and the “macro-circuit
theory.” The global theory of WM disruption in SZ suggests that
WM is compromised uniformly throughout the brain,whereas the
macro-circuit theory proposes that speciﬁc WM tracts are com-
promised, which may be a cause or consequence of abnormalities
in the gray matter regions these tracts connect (Buchsbaum et al.,
2006; Konrad andWinterer, 2008).
Diffusion tensor imaging
Diffusion tensor imaging is a method used to measure the dif-
fusion of water molecules in brain WM. Healthy brain WM has
a complex axonal structure and, therefore, water diffusion will
be restricted along the direction of the axons. This is known as
anisotropic diffusion.However, if brainWMis compromisedwater
diffusion can become less restricted (i.e., isotropic). A common
measure derived from DTI to describe the degree of anisotropy
during diffusion is fractional anisotropy (FA).However,othermea-
sures of diffusion such as radial and axial diffusivity can also be
obtained. Based on the voxel-wise information provided by DTI,
ﬁber tracking algorithms can be implemented in regions of interest
to reconstruct the underlying three-dimensional WM pathways.
While caution must be exercised when interpreting measures of
anisotropy (Jones, 2008, 2010; Tournier et al., 2011), such mea-
sures are thought to index structural integrity of WM tracts and,
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thus, may be reasonably considered to be implicit indices of brain
connectivity.
WM integrity and SZ: evidence from DTI investigations
A review by Kubicki et al. (2007) noted that themost frequent pos-
itive ﬁndings of DTI studies in SZ were decreased FA within the
prefrontal and temporal lobes, as well as abnormalities within the
ﬁber bundles connecting these regions. WM tracts within these
regions that were found to be affected included: (a) the uncinate
fasciculus that connects parts of the limbic system with areas in
the frontal cortex; (b) the cingulum bundle; and (c) the arcu-
ate fasciculus that connects part of the temporo-parietal junction
with the frontal cortex and is thought to be part of the supe-
rior longitudinal fasciculus. Ellison-Wright and Bullmore (2009)
conducted a meta-analysis of 15 DTI studies, which included
a total of 407 patients with SZ and 383 comparison subjects.
Results identiﬁed two regions of FA decreases in SZ subjects in
comparison to controls. The ﬁrst region was in the left frontal
deep WM, which is traversed by WM tracts interconnecting the
frontal lobe, thalamus and cingulate gyrus. The tracts include:
(a) anterior thalamic radiation (ATR); (b) corticobulbar tracts;
(c) inter-hemispheric ﬁbers running through the genu of the
corpus callosum; (d) the inferior fronto-occipital fasciculus; (e)
the cingulum bundle. The second region was in the left tempo-
ral deep WM that is traversed by WM tracts interconnecting the
frontal lobe, insula,hippocampus–amygdala, temporal and occipi-
tal lobes. These tracts include: (a) inter-hemispheric ﬁbers running
through the splenium of the corpus callosum; (b) the inferior
fronto-occipital fasciculus; (c) the inferior longitudinal fasciculus;
(d) the fornix/striaterminalis. These two reviews of the current
DTI/SZ literature suggest that speciﬁc networks of WM are dis-
rupted in SZ providing support for the macro-circuit theory of
WM disruption in the disease.
Pathophysiological mechanisms of compromised WM
As the integrity of axons is dependent on myelination and factors
inﬂuencing myelination, it is possible that myelin and oligo-
dendroglia function also plays a role in the pathophysiology of
SZ (Davis et al., 2003). Since myelination also impacts synap-
tic plasticity, oligodendrocyte abnormality and subsequent myelin
dysfunction may contribute to the development of SZ by alter-
ing synaptic function and information processing (Fields, 2008).
Conduction velocity along axons is also thought to be essen-
tial for learning processes (Fields, 2008) and disruption of this
has the potential to lead to the range of cognitive impairments
observed in SZ (Tanaka et al., 2009). Furthermore, oligodendro-
cyte and myelin dysfunction also impacts neuronal activity that
is relevant to SZ, such as glutamate and dopamine signaling. Evi-
dence from psychotic episodes of multiple sclerosis (MS) patients
and experimentally induced demyelination suggests that altered
myelin function leads to altered dopamine signaling (Takahashi
et al., 2011). Similar analyses have also revealed increased lev-
els of glutamate in brains of MS patients as well as increased
expression of glutamate receptors on oligodendrocytes (Takahashi
et al., 2011). Glutamate transporters are also present on oligoden-
droglia and are thought to regulate glutamate concentrations to
prevent glutamate-induced excitotoxicity (Pitt et al., 2003). Over
activation of oligodendroglial glutamate receptors is excitotoxic
and can result in oligodendrocyte death (Davis et al., 2003).
Recently, attention has turned toward the consideration of
genes that inﬂuence oligodendrocyte architecture and how these
genes may also be associated with SZ risk. Hakak et al. (2001)
examined the expression of 6500 genes derived from postmortem
cortical tissue of SZ patients and controls. The expression levels of
six myelin-related genes were signiﬁcantly down regulated for SZ
patients in comparison to control subjects. These genes included:
myelin-associated glycoprotein (MAG), CNP, myelin and lym-
phocyte protein (MAL), gelosn (GSN), ErbB3, and transferring.
Down regulation of these genes supports the view that oligoden-
drocytes, the cell type from which all these genes derive in the
brain, contribute to the pathophysiology of SZ.
USING IMAGING GENETICS TO EXAMINE NEURAL CONNECTIVITY
Two previousmeta-analyses have considered themagnitude of the
impact of gene variants on brain function, each reporting large
effect sizes. Munafo et al. (2008) examined the effect sizes of the
5-HTTLPR polymorphism and amygdala activation, while Mier
et al. (2010) examined the magnitude of effect of the catechol-O-
methyltransferase (COMT ) Val158Met polymorphism on brain
function, reporting association between this variant and activa-
tion of the PFC. However, to our knowledge no studies have
speciﬁcally considered the effect size of gene variants in studies
of functional and structural connectivity, or compared effect sizes
between these phenotypes. Consideration of the relative impact
of these two measures of brain connectivity will help us to bet-
ter delineate whether or not one phenotype is more proximal to
the underlying genetics, and thus preferential as an intermediate
phenotype for studies of SZ. This could not only aid our theoret-
ical understanding of the SZ disease trajectory but may also have
signiﬁcant practical implications for future investigations.
METHODS
We searched for relevant papers based on the criteria of
studies that included genes implicated in SZ risk and mea-
sures of either DTI or functional connectivity. PubMed
(http://www.ncbi.nlm.nih.gov/pubmed/) was used to search for
relevant functional and structural connectivity papers published
until June 2011. The following search terms were included in this
search: [schizophrenia OR schiz∗] AND [genetic or gene∗] AND
[MRI OR DTI] AND [connectivity] AND [structural OR func-
tional]. This literature search was supplemented with a review of
the references from each of the papers identiﬁed. In total 24 stud-
ies meeting these search criteria were retrieved, including 12 DTI
studies and 12 functional connectivity studies. Individual studies
differed slightly in terms of MRI acquisition and analysis parame-
ters (e.g., voxel size, size of Gaussian function used for smoothing).
However, all studies were included regardless of these differences,
due to the small number of studies available. Where the data pre-
sented were insufﬁcient for effect size calculations, a request for
supplementary data was sent to the corresponding author. This
led to data being available for 19 out of the 24 studies identiﬁed
(10 DTI studies and 9 functional connectivity studies).
Effect size calculations were performed using two online
effect size calculators http://www.uccs.edu/∼faculty/lbecker/ and
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www.lyonsmorris.com/ma1/index.cfm Estimates of effect size were
calculated based upon either descriptive data (i.e., mean, SD, and
N ), or statistical data (i.e., t, F). The purpose of this paper was to
estimate differences in effect size rather than differences in direc-
tion of effect. That is we were interested in delineating the relative
sensitivity of these two indices of brain connectivity to genetic
variability, rather than accounting for the overall impact of a spe-
ciﬁc variant or group of variants. Therefore, direction of effect was
not included in the analysis and all effect sizes were considered
positive.
A random effects meta-analyses considering the relative differ-
ence in the impact of SZ risk genes on functional and structural
connectivity was carried out using the comprehensive meta analy-
sis (CMA; software package v2; www.meta-analysis.com). For the
purposes of this analysis, Hedge’s g and its associated variance
were calculated for the outcome of each signiﬁcant effect in each
study. As with prior estimates of Cohen’s d, g was calculated using
a variety of input variables including descriptive and inferential
statistics. In the ﬁrst analysis, the largest effect for each study was
chosen so to reﬂect the maximal sensitivity to gene effects within
each investigation. In a secondary analysis, all of the effects for
each signiﬁcant result in each paper were taken into account. This
strategy allowed us to account for both variability in the number
and range of signiﬁcant effects reported across methodologies.
RESULTS
Overall, 8 fMRI and 10 DTI studies were included in the meta-
analysis. Summary information from all of these studies is
presented in Tables 1 and 2.
FUNCTIONAL CONNECTIVITY
A total of 44 effect sizes were calculated from the functional
connectivity studies. Effect sizes (i.e., Cohen’s d) ranged from
medium to large (d= 0.46–1.65) with an average effect size of 0.76
(SD± 0.23). The largest effect size (d= 1.65) was reported for the
impact of a single nucleotide polymorphism (SNP) in ZNF804A
on functional connectivity within the right PFC in SZ patients
(Rasetti et al., 2011). While large effect sizes (d> 0.7) were also
calculated in other studies examining the effects of this SNP on
functional connectivity (Esslinger et al., 2009, 2011; Rasetti et al.,
2011) these results were not consistent: the smallest effect size was
also reported for this SNP (d= 0.46; Paulus et al., 2011).
STRUCTURAL CONNECTIVITY
A total of 24 effect sizes were calculated for structural connectivity
investigations. Effect sizes ranged from small to large (d= 0.38–
1.95) with an average effect size of 1.04 (SD= 0.42). The largest
effect size was revealed for the impact of NRG1 SNP on WM
integrity in the left ATR (Sprooten et al., 2009). Large effect sizes
were also observed for all the other studies examining the impact
of NRG1 on WM integrity (all d> 0.80). Similar effect sizes were
revealed for studies investigating the ErbB4 gene, with Cohen’s d
for these studies ranging from 0.81 to 1.41. Both theMTHFR gene
and the 5-HTT gene had large effect sizes of 1.29 and 0.92 respec-
tively. The smallest effect size of 0.38 was computed for the effect
of a COMT haplotype on left prefrontal WM integrity. Cohen’s d
for the COMT papers ranged from 0.38 to 0.76.
META-ANALYSIS
In our ﬁrstmeta-analysis we considered only the largest effect sizes
in each study (Figure 1; Table 3). This analysis revealed no signif-
icant difference in outcome variability between the effect sizes for
functional and structural studies (Q = 2.171, p = 0.141). Our sec-
ond analysis examined all of the effects for each result in each
paper (Figure 2; Table 3). This analysis revealed a signiﬁcant dif-
ference between effects sizes in functional and structural studies
(Q = 6.928, p = 0.008).
DISCUSSION
The aimof this reviewwas to consider the nature andmagnitude of
effect of SZ risk variants on functional and structural connectivity.
Our focus was the overall magnitude of such effects, rather than
delineating the direction of effect of a speciﬁc variant. Therefore,
we focused on the size, rather than the direction of individuals
results. Examining the effect of risk variants on connectivity in
fMRI andDTI studies, we found that variation in genes implicated
inneurotransmission,plasticity,development andmyelin function
are associated with altered neural connectivity. Meta-analyses of
effect size data revealed that there was no signiﬁcant difference
between the effect sizes of functional and structural studies when
the largest effect size of each study was analyzed. However, when
all effects were taken into consideration, the effect sizes for the
structural studies were larger than in the functional connectivity
studies, and there was a signiﬁcant lack of homogeneity across
the modalities. Mostly likely, given the absence of difference when
only the largest effects from each set of studies are considered, this
difference reﬂects the greater variation in effect sizes in structural
studies compared to fMRI studies.
FUNCTIONAL CONNECTIVITY STUDIES
To date, the effects on functional connectivity of a number of can-
didate SZ genes (DISC1, PRODH, PPP1R1B) and one gene with
genome-wide signiﬁcance for SZ risk (ZNF804A), each of which
were found to be associated with altered functional connectivity.
The mean effect size for the functional connectivity studies was
large (d = 0.76), with the largest effect size reported for the impact
of the rs1344706 variant in ZNF804A.The ZNF804A risk variant
rs1344706 has become the focus of much interest in SZ research
over the last 3 years, as GWAS and follow-up analyses have estab-
lished strong evidence for a link between this variant and risk for
the disorder (O’Donovan et al., 2008). While the function of the
ZNF804A gene is unknown, it has been speculated to play a role
in gene regulation (O’Donovan et al., 2008) and glutamate and
dopamine transmission (Esslinger et al., 2009). ZNF804A repre-
sents the only SZ-implicated gene that we are aware of whose
effects on functional connectivity have been investigated now on
a number of occasions. Importantly, the size of effect reported for
this variant has varied considerably. For example, as well as having
the highest effect of the variants considered it also has the lowest
effect of the variants considered (d = 0.46; Paulus et al., 2011), sug-
gesting that establishing the true effect of any variant on functional
connectivity will require investigation in multiple and adequately
powered cohorts.Variants from the candidate SZ gene literature by
comparison, while each showing large effects on functional con-
nectivity (d-range: 0.73–0.87), have each only been the subject of
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Table 1 | Details of the functional connectivity studies included in this meta-analysis.
First author and date Gene of interest Connectivity Method Statistic n Cohen’s d
Meyer-Lindenberg et al.
(2007)
PPP1R1B L. PFC – striatum, frequent haplotype
carriers>non-frequent haplotype carriers
SC 4.41
†
126 0.79
R. PFC – striatum, frequent haplotype
carriers>non-frequent haplotype carriers
SC 4.57
†
126 0.82
L. PFC – striatum, frequent haplotype
carriers>non-frequent haplotype carriers
SC 4.31
†
142 0.73
Kempf et al. (2008) PRODH dlPFC – striatum, reference haplotype
carriers>protective haplotype carriers
SC 3.91* 103(108
total)
0.79
dlPFC – striatum, risk haplotype carriers>protective
haplotype carriers
SC 2.88* 48(108
total)
0.87
Di Giorgio et al. (2008) DISC1 R. hippocampus – R. dlPFC, Ser/Ser>Cys carriers PPI 3.58* 80 0.81
Esslinger et al. (2009) ZNF804A R. dlPFC – L. hippocampus, AA>CA>CC SC 3.98§ 115 0.75
R. dlPFC – R. dlPFC, CC>CA>AA SC 4.05§ 115 0.77
R. dlPFC – L. dlPFC, CC>CA>AA SC 3.59§ 115 0.68
Esslinger et al. (2011) ZNF804A R. dlPFC – L. MFG, CC>CA>AA SC 5.09
‡
111 0.98
R. dlPFC – R. MFG, CC>CA>AA SC 4.68
‡
111 0.9
R. dlPFC – R. SFG, CC>CA>AA SC 4.5
‡
111 0.86
R. dlPFC – L. MFG, CC>CA>AA SC 3.9
‡
111 0.74
R. dlPFC – L. hippocampus, AA>CA>CC SC 4.28§ 111 0.82
R. dlPFC – R. hippocampus, AA>CA>CC SC 3.34§ 111 0.64
Walter et al. (2011) ZNF804A L. TPJ – L. inferior frontal gyrus, AA>CA>CC SC 3.77* 109 0.73
L. TPJ – L. cuneus, AA>CA>CC SC 3.76* 109 0.73
L. TPJ – R. thalamus, AA>CA>CC SC 3.68* 109 0.72
L. TPJ – L. caudatetail, AA>CA>CC SC 3.96* 109 0.77
R. dlPFC – R. precentral gyrus, CC>CA>AA SC 4.27* 109 0.83
R. dlPFC – L. MTG, CC>CA>AA SC 3.32* 109 0.65
R. dlPFC – L. LG, CC>CA>AA SC 3.83* 109 0.74
Paulus et al. (2011) ZNF804A R. dlPFC – L. HF, AA>CA>CC SC 2.3* 94 0.48
R. dlPFC – L. HF, AA>CA>CC SC 2.22* 94 0.46
R. dlPFC – R. HF, AA>CA>CC SC 2.85* 94 0.59
R. dlPFC – R. HF, AA>CA>CC SC 2.19* 94 0.46
R. dlPFC – L. dlPFC, AA>CA>CC SC 3.42* 94 0.71
R. dlPFC – L. dlPFC, AA>CA>CC SC 2.26* 94 0.47
R. dlPFC – R. dlPFC, AA>CA>CC SC 2.39* 94 0.5
R. dlPFC – R. dlPFC, AA>CA>CC SC 2.33* 94 0.49
R. dlPFC – R. dlPFC, AA>CA>CC SC 2.33* 94 0.49
R. dlPFC – R. dlPFC, CC>CA>AA SC 2.43* 94 0.51
Rasetti et al. (2011) ZNF804A Controls: R. dlPFC – L. HF, CC>CA>AA SC 2.72* 96 0.56
Controls: R. dlPFC – L. dlPFC, CC>CA>AA SC 3.65* 96 0.75
Controls: R. dlPFC – R. PFC, CC>CA>AA SC 3.21* 96 0.66
Controls: R. dlPFC – L. hippocampus, CC>CA>AA PPI 3.74§ 96 0.77
Controls: R. dlPFC – R. hippocampus, CC>CA>AA PPI 2.89
†
96 0.6
Siblings: R. dlPFC – R. hippocampus, AA – abnormal
coupling
SC 2.53* 83 0.57
Siblings: R. dlPFC – L. PFC, AA<C carriers SC 2.77* 83 0.62
Siblings: R. dlPFC – R. dlPFC, AA – greater
task-related modulation of coupling
PPI 4.36§ 83 0.98
Patients: R. dlPFC – R. PFC, CC>CA>AA SC 4.58§ 33 1.65
Patients: R. dlPFC – L. hippocampus, AA< C carriers PPI 3.56§ 33 1.28
Patients: R. dlPFC – L. PFC, CC>CA>AA PPI 2.84* 33 1.02
Patients: R. dlPFC – R. PFC, CC>CA>AA PPI 3.40* 33 1.22
n, sample size; SC, seeded connectivity; PPI, psychophysiological interaction; dlPFC, dorsolateral prefrontal cortex; MFG, middle frontal gyrus; SFG, superior frontal
gyrus; TPJ, temporo-parietal junction; MTG, middle temporal gyrus; LG, lingual gyrus; IFG, inferior frontal gyrus; *p-value is uncorrected for multiple comparisons;
† false discovery rate corrected within region of interest; ‡ false discovery rate corrected for whole brain; §family wise error corrected within region of interest.
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Table 2 | Details of the structural connectivity studies using DTI included in this meta-analysis.
First author and date Gene Connectivity Statistic (t or F ) N Cohen’s d
McIntosh et al. (2008) NRG1 SNP8NRG243177 Reduced FA in ALIC t =2.65* 43 0.83
Winterer et al. (2008) NRG1 SNP8NRG221533 Reduced FA in MF subcortical WM t =4.67*** 50 1.35
Sprooten et al. (2009) NRG1 SNP8NRG221533 Reduced FA in left ATR t =5.52*** 28 1.95
NRG1 SNP8NRG243177 Reduced FA in left ATR t =4.69*** 28 1.66
Wang et al. (2009) NRG1 SNP8NRG221533 Reduced FA in anterior cingulum F =5.27* 31 0.86
NRG1 SNP8NRG221533 Reduced FA in anterior cingulum F =18*** 34 1.54
Konrad et al. (2009) ErbB4 rs707284 Reduced FA in temporal lobeWM t =4.24*** 50 1.22
ErbB4 rs758440 Reduced FA in temporal lobeWM t =2.81*** 50 0.81
ErbB4 rs839541 Reduced FA in temporal lobeWM t =4.31*** 50 1.24
ErbB4 rs839523 Reduced FA in temporal lobeWM t =4.73*** 50 1.37
G-T-G-T versus lower risk Reduced FA in temporal lobeWM t =3.85*** 32 1.41
G-T-G-T versus all other Reduced FA in temporal lobeWM t =3.2*** 50 0.92
All other versus non-risk Reduced FA in temporal lobeWM t =3.66*** 50 1.057
Zuliani et al. (2011) ErbB4 rs4673628 Reduced FA in right ALIC t =3.48*? 36 1.19
ErbB4 rs4673629 Reduced FA in left ALIC t =3.98*? 36 1.37
Thomason et al. (2010) COMT val158met Main effect of genotype on FA, AD, RD in GCC F =3.04* 40 0.76
COMT val158met Main effect of genotype on FA, AD, RD in ATR F =2.79* 40 0.7
COMT val158met Main effect of genotype on FA, AD, RD in UF F =2.47* 40 0.6
Liu et al. (2010) COMT val158met Decreased FA in right CST for Val/Val carriers F =5.197* 79 0.51
LPS, HPS and APS haplotypes Association with mean FA in left PF lobe F =2.79* 68 0.38
LPS, HPS and APS haplotypes Association with mean FA in right PF lobe F =3.58* 68 0.47
LPS, HPS and APS haplotypes Association with mean FA in right UF F =3.507* 68 0.47
Roffman et al. (2011) MTHFR 677T Reduced FA in bilateral DACC F =6.59* 18 1.29
Pacheco et al. (2009) 5-HTTLPR Increasing number of low expressing
alleles – decreasing FA in left FUF
t =−3.03* 37 −0.92
n, sample size; FA, fractional anisotropy; MF, medial frontal;WM, white matter; ALIC, anterior limb of internal capsule; AD, axial diffusivity; RD, radial diffusivity; ATR,
anterior thalamic radiation; UF,uncinate fasciculus; GCC, genu of corpus callosum; CST, corticospinal tract; PF, prefrontal; DACC, dorsal anterior cingulate cortex; FUF,
frontal uncinate fasciculus; *p<0.05; ***p<0.001; *?p<0.05 family wise error corrected
single studies to date (DISC1; Di Giorgio et al., 2008; PRODH ;
Kempf et al., 2008; PPP1R1B; Meyer-Lindenberg et al., 2007).
In 10 of the 12 fMRI studies included in this review, SZ risk
variants were reported to affect functional circuits that included
the PFC during the performance of a variety of tasks, such as
memory encoding and retrieval, working memory, emotion pro-
cessing, and during rest. These ﬁndings reﬂect the PFC’s dominant
role in many processes related to higher cognitive functioning,
making it consistently implicated in SZ pathogenesis (Callicott
et al., 2000).There are several possibilities for why PFC function is
altered in SZ as reﬂected in these studies. For example, the“reduced
neuropil hypothesis” of schizophrenia suggests that reduced PFC
gray matter (observed in the absence of a concomitant change
in cell numbers)may reﬂect decreased dendritic spines/axon ter-
minals; the inefﬁciencies synaptic transmission expected to result
may well lead to the altered functional connectivity patterns seen
here (Selemon and Goldman-Rakic, 1999).
STRUCTURAL CONNECTIVITY STUDIES
A number of candidate SZ risk genes have been investigated in
terms of their effects on structural connectivity. This includes
genes that are involved inmyelination (NRG1, ErbB4) neurotrans-
mission (COMT, MTHFR, 5-HTTLPR) and neurodevelopment
(BDNF and DISC1). Almost all variants considered here were
associated with signiﬁcant variation in FA scores using DTI.
The average effect size for these studies was large, with the
largest effect size computed for the impact of NRG1 on FA in the
left ATR (Sprooten et al., 2009). The NRG1 gene codes for the
NRG1 protein, that is involved in growth and differentiation of
neuronal and glial cells and is necessary for the normal develop-
ment of the nervous system. ErbB4 is a receptor for the NRG1
protein. It is thought that NRG1 may mediate its effects on SZ
susceptibility through functional interaction with ErbB4 (Nor-
ton et al., 2006). Interestingly, ErbB4 was also observed here to
show effects on WM integrity that would be considered to be
in of large magnitude. The role of these genes in myelin func-
tion suggests a mechanism by which they confer risk for SZ. The
relatively large impact of these genes on structural connectivity,
noted here, suggests that genetically mediated “dysconnectivity”
in SZ results frommacro-circuitWM abnormalities in addition to
micro-circuit synaptic plasticity. However, since oligodendrocyte
dysfunction may also impact synaptic function and information
processing via a myelin-dependent impact on synaptic plasticity
(Fields, 2008), it remains to be established if the inﬂuence of these
variants is speciﬁc to structural connectivity or if they also impact
upon functional connectivity.
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FIGURE 1 | Forest plot reporting Hedges’ g and 95% CI for the analysis showing the largest effect size in each paper. CI, conﬁdence interval; g, Hedges’
g; SE, standard error.
Table 3 | Results of random-effects meta-analysis comparing the relative difference in the impact of variants on functional and structural
connectivity.
Effect size and 95% confidence interval Heterogeneity
No. of studies Point estimate SE Variance Lower limit Upper limit Q-value df (Q) p-value
MAXIMUM ESTIMATE
Functional 9 0.812 0.072 0.005 0.671 0.953
Structural 10 1.067 0.158 0.025 0.758 0.377
Total between 2.171 1 0.141
ALL ESTIMATES
Functional 44 0.687 0.032 0.001 0.625 0.750
Structural 24 0.934 0.088 0.008 0.761 1.108
Total between 6.928 1 0.008
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FIGURE 2 | Forest plot reporting Hedges’ g and 95% CI for each functional and structural connectivity analysis. CI, conﬁdence interval; g, Hedges’ g; SE,
standard error.
Other gene variants associated with variation in WM connec-
tivity included COMT, MTHFR, 5-HTTLPR, BDNF and DISC1.
Results for both the MTHFR gene and the 5-HTT gene had large
effect sizes. The MTHFR gene codes for the an enzyme that plays
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a role in the regulation of intracellular methylation reactions and
may inﬂuence dopamine signaling (Roffman et al., 2008). The
hypofunctional 677T variant of this gene has been associated with
increased SZ risk (Gilbody et al., 2007). The reuptake of serotonin
to the presynaptic neuron for recycling or degradation after sero-
tonin release is regulated by the serotonin transporter (5-HTT).
Although the 5-HTTLPR polymorphism has been found to be
associated with SZ in a South India population (Vijayan et al.,
2009), other genetic association studies have given conﬂicting
results (Rao et al., 1998). The smallest effect size was computed for
the effect of a COMT haplotype on left prefrontal WM integrity
(Liu et al., 2010). The COMT gene codes for an enzyme that is
involved in the degradation of dopamine. Therefore, the evidence
from DTI studies investigating the impact of the COMT gene on
WM indicates that neurosignalling processes involved in SZ may
also impact structural connectivity. Finally, BDNF (Chiang et al.,
2011) and DISC1 (Sprooten et al., 2011) which are genes that are
crucial for neurodevelopment, were also associated withWM con-
nectivity in SZ. However, as insufﬁcient data was available, effect
sizes for these studies were not calculated.
META-ANALYSIS
The papers included in this review most commonly report a large
effect of gene variants on functional and structural connectivity.
This result is similar to previousmeta-analyses in imaging genetics,
which reported large effect sizes of gene variants (i.e., 5-HTTLPR
polymorphism and the COMT Val158Met polymorphism) on
brain function (Munafo et al., 2008; Mier et al., 2010). This result
is also consistent with the intermediate phenotype hypothesis that
common SZ risk variants will show small effects on behavior and
disease risk, but large effects at the level of the brain (Tost et al.,
2011).
When the maximum effect size value for each paper in our
meta-analysis was compared between fMRI and DTI studies, no
signiﬁcant difference was found between these measures. As only
a small number of studies were obtained, there may be a lack of
power to detect such differences. However, examination of effect
sizes for all signiﬁcant effects indicate that structural connectiv-
ity studies were associated with overall larger and more variable
effect sizes. This suggests that measures of structural connectivity,
such as DTI, may be sensitive to a wider range of effects com-
pared to functional connectivity measures, which may only be
able to accurately detect large effects. This result may also indi-
cate that structural connectivity is closer to the level of genes than
functional connectivity.
LIMITATIONS
A number of limitations need to be considered in evaluating the
ﬁndings of the present study. Firstly, many of the studies included
in the meta-analysis have examined the effects of polymorphisms
that do not have consistent association with SZ phenotypes. This
makes it difﬁcult to determine the relevance of these genes for
our understanding of SZ pathogenesis (for a review, see Meyer-
Lindenberg, 2010). Secondly, it should also be noted that the
sample sizes included in these studies are relatively small and thus,
are under powered to detect differences in brain connectivity con-
ferred by individual variants. Due to the interplay between sample
size, power, and effect size, smaller studies generally show larger
effects in meta-analyses (Sterne et al., 2000) and may lack sufﬁ-
cient power to detect smaller effects. Related to the general issue of
sample size, it is important to note that the average sample size of
the studies utilizing DTI was smaller than that for the functional
studies. As a result, the effect sizes for the structural papers may
be over-inﬂated. However, the results of our meta-analysis suggest
that despite smaller samples, the structural imaging studies were
associated with a wider range of effects, suggesting that sample size
is not the only factor at play here.
Due to the under-representation of publications with negative
results, the studies included in this review may not be represen-
tative of connectivity research in its entirety, but rather a bias
toward only publish papers showing statistically signiﬁcant results.
Therefore, while our effect size ﬁndings are calculated on the basis
of published effect sizes, it is possible that the true effect sizes
are smaller, and to an extent that is unknown. Similarly, it is also
unclear to what extent differences in scanning parameters between
the studies included in this meta-analysis inﬂuenced results. More
systematic investigation of these differences will in the future be
possible with the accumulation of more studies.
An additional limitation in the studies considered here is that
each investigation examined the effects of only one particular vari-
ant. However, the true function of these genes may be affected by
additive or epistatic interactions with other variants. As such, the
results presented in this review may be incomplete without taking
these interactions into account (Nicodemus et al., 2010).
Finally, it is probable that these results could be impacted by dif-
ferences in functional and structural methodological approaches.
For example, a number of analysis methods can be employed to
measure functional connectivity between brain regions. However,
we are not currently aware of the relative strengths and weaknesses
of these different approaches. There are also various approaches
used to quantify WM connectivity using DTI, which also pose
different strengths and limitations (see Jones, 2010 for a review).
CONCLUSIONS AND FUTURE DIRECTIONS
In a short period of time, imaging genetics has made important
progress in delineating genetic effects on neural connectivity. In
particular, it has established neural connectivity as a key interme-
diate phenotype for SZ, which can be used to explore the complex
trajectory from genetic risk to clinical symptoms.
Despite the progress that has taken place, we believe important
advances can bemade in this research ﬁeld in four key areas. Firstly,
future studies should examine the effects of gene variants onneural
connectivity in larger sample sizes, as this can provide the extra
statistical power that may be necessary to detect smaller effects
of these genes. Multi-site research projects, such as the IMAGEN
project in Europe, may be particularly suited for compiling imag-
ing and genetic databases of thousands of subjects (Schumann
et al., 2010). Secondly, future studies should examine additive and
epistatic effects of gene variants on neural connectivity, as these
variants are unlikely to be working in isolation. Thirdly, future
studies should examine the effects of risk variants in healthy con-
trols and SZ patients as the opposite effects of these genes on
connectivity can be found in these different groups (e.g., Prata
et al., 2009).
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Finally, future studies could beneﬁt from the novel application
of recently developed analysis techniques to imaging genetics. For
example, DCM hold potential for constructing models of chang-
ing brain interactions that also take into account genetic vari-
ation (Meyer-Lindenberg, 2009). Other recent advances include
the use of parallel ICA to simultaneously analyze independent
components derived from fMRI and genetic data (Liu et al.,
2009). For example, Meda et al. (2010) used this technique in
a pilot study to identify simultaneous independent components
of fMRI data and SNP data, derived from a sample of 35 con-
trols and 31 SZ patients. The authors found correlations between
different neural networks and a number of SNPs, including poly-
morphisms involved in altered dopamine transmission. While
the authors only included a small number of SNPs and a small
sample size, this research suggests a powerful new approach for
future studies examining the effects of SZ risk variants on func-
tional brain networks. Similarly, more advanced DTI techniques
could be implemented that use high angular resolution to account
for multiple crossing ﬁbers within a single voxel. Such imag-
ing techniques include Q-space approaches and mixture mod-
els (Tournier et al., 2011). These models provide mathematical
alternatives to the tensor model for the characterization of dif-
fusion processes. Furthermore, Jones (2010) recommends the
integration of DTI with other measures of WM such as mea-
sures of axon density and myelination that can be acquired using
techniques such as magnetization transfer or multicomponent
relaxometry.
In conclusion, the present meta-analysis examined the nature
and magnitude of effect of SZ risk variants on functional and
structural connectivity.Gene variants impactinguponboth synap-
tic plasticity and axonal connectivity have been associated with
altered neural connectivity in patients and healthy controls. As
such, it is likely that both mechanisms make important contri-
butions to SZ pathogenesis. On average, risk variants exert a large
effect on functional and structural connectivity. There is alsomore
variability in the effects of variants on structural connectivity,
compared to functional connectivity. While imaging genetics has
made considerable progress in the ﬁeld of neural connectivity in a
short period of time, important advances are still to be made. It is
hoped that this research will lead to a better understanding of the
biological mechanisms mediating genetic risk for SZ, which can
then be used to direct novel treatments for the disorder.
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